Medicine and Dentistry
Radiation Therapy
100%
Neoplasm
38%
Prostate Cancer
33%
Overall Survival
32%
Oncology
27%
Intensity Modulated Radiation Therapy
20%
Stereotactic Body Radiation Therapy
19%
Non Small Cell Lung Cancer
18%
Malignant Neoplasm
18%
Diseases
18%
Clinical Trial
14%
Breast Cancer
13%
Radiation Oncology
13%
Brachytherapy
13%
Recurrent Disease
13%
Treatment Planning
12%
Magnetic Resonance Imaging
11%
Surgery
11%
Hazard Ratio
10%
External Beam Radiotherapy
10%
Lung Cancer
9%
Quality of Life
9%
Proton Therapy
9%
Chemoradiotherapy
8%
Oropharynx Squamous Cell Carcinoma
8%
Wart Virus
8%
Pelvis
8%
Computer Assisted Tomography
8%
Drug Megadose
8%
Progression Free Survival
7%
Neck
7%
Cervical Cancer
7%
Metastatic Carcinoma
7%
Cancer
7%
Lymph Node
7%
Positron Emission Tomography
7%
Lung
6%
Bladder
6%
Prostate Specific Antigen
6%
Head and Neck Cancer
6%
Conformal Radiotherapy
6%
Contouring
6%
Glioblastoma
6%
Arm
6%
Bladder Cancer
6%
Adverse Event
6%
Stereotactic Radiosurgery
5%
Disease Free Survival
5%
Distant Metastasis
5%
Brain Metastasis
5%
Radiation Oncologist
5%
Androgen Deprivation Therapy
5%
Oropharynx Carcinoma
5%
Low Drug Dose
5%
Prostatectomy
5%
Carcinoma
5%
Keyphrases
Radiation Therapy
49%
Overall Survival
31%
Radiotherapy
23%
Tumor
20%
Non-small Cell Lung Cancer (NSCLC)
14%
Prostate Cancer
14%
Stereotactic Body Radiation Therapy
14%
Radiation Therapy Oncology Group
13%
Radiation Oncology
13%
Confidence Interval
13%
Intensity-modulated Radiation Therapy
12%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
12%
NRG Oncology
11%
Hazard Ratio
10%
External Beam Radiotherapy
9%
High-risk Human Papillomavirus (HR-HPV)
9%
Chemotherapy
9%
Local Control
9%
Magnetic Resonance Imaging
8%
Progression-free Survival
8%
Clinical Trials
7%
Adaptive Radiotherapy
7%
Head-and-neck Cancer
7%
Brachytherapy
7%
Treatment Planning
7%
Quality Assurance
7%
Hyperthermia
7%
Prostate
7%
Phase II Trial
7%
Head-and-neck
6%
High Dose
6%
Stereotactic Radiosurgery
6%
Clinical Outcomes
6%
Cervical Cancer
6%
Prostate-specific Antigen
6%
Irradiation
6%
Brain Metastases
6%
Quality of Life
6%
High Risk
6%
Radiation Dose
6%
Proton Therapy
6%
Androgen Deprivation Therapy
6%
Distant Metastasis
6%
Three-dimensional Conformal Radiotherapy
6%
Computed Tomography
6%
Radiation Oncologist
5%
Clinical Target Volume
5%
Multi-institutional
5%
Dose Escalation
5%
Bladder Cancer
5%
Intensity-modulated Radiotherapy
5%
Disease-free Survival
5%
Treatment Plan
5%
Glioblastoma
5%
Positron Emission Tomography
5%
Multivariate Analysis
5%
Stereotactic Body Radiotherapy
5%